Renaissance Technologies (RenTech)'s AUPH Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 1.59 M shares of Aurinia Pharmaceuticals Inc. (AUPH) worth $25.36 M, representing 0.04% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in AUPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 1.23 M shares. Largest reduction occurred in Q2 2022, reducing 1.1 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Aurinia Pharmaceuticals (AUPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aurinia Pharmaceuticals (AUPH) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +140,535 | Add 9.69% | 1.59 M | $15.95 |
| Q3 2025 | +291,800 | Add 25.20% | 1.45 M | $11.05 |
| Q2 2025 | +219,200 | Add 23.35% | 1.16 M | $8.47 |
| Q1 2025 | +237,700 | Add 33.91% | 938,600 | $8.04 |
| Q4 2024 | +214,200 | Add 44.01% | 700,900 | $8.98 |
| Q3 2024 | +285,200 | Add 141.54% | 486,700 | $7.33 |
| Q2 2024 | -43,100 | Reduce 17.62% | 201,500 | $5.71 |
| Q1 2024 | +109,600 | Add 81.19% | 244,600 | $5.01 |
| Q4 2023 | -528,000 | Reduce 79.64% | 135,000 | $8.99 |
| Q3 2023 | -867,400 | Reduce 56.68% | 663,000 | $7.77 |
| Q2 2023 | -53,800 | Reduce 3.40% | 1.53 M | $0.01 |
| Q1 2023 | -69,000 | Reduce 4.17% | 1.58 M | $0.01 |
| Q4 2022 | +919,400 | Add 125.29% | 1.65 M | $0.00 |
| Q3 2022 | +135,200 | Add 22.59% | 733,800 | $7.52 |
| Q2 2022 | -1.1 M | Reduce 64.67% | 598,600 | $10.05 |
| Q1 2022 | +1.23 M | Add 262.73% | 1.69 M | $12.38 |
| Q4 2021 | +467,071 | New Buy | 467,071 | $22.87 |
| Q4 2020 | -239,400 | Sold Out | 0 | $0.00 |
| Q3 2020 | -918,100 | Reduce 79.32% | 239,400 | $14.73 |
| Q2 2020 | -281,300 | Reduce 19.55% | 1.16 M | $16.25 |
| Q1 2020 | +860,266 | Add 148.70% | 1.44 M | $14.51 |
| Q4 2019 | +567,789 | Add 5284.22% | 578,534 | $20.26 |
| Q3 2019 | -57,878 | Reduce 84.34% | 10,745 | $5.30 |
| Q2 2019 | -111,077 | Reduce 61.81% | 68,623 | $6.59 |
| Q1 2019 | +179,700 | New Buy | 179,700 | $6.50 |
| Q1 2018 | -53,001 | Sold Out | 0 | $0.00 |
| Q4 2017 | -5,300 | Reduce 9.09% | 53,001 | $4.57 |
| Q3 2017 | -12,700 | Reduce 17.89% | 58,301 | $6.28 |
| Q2 2017 | -34,699 | Reduce 32.83% | 71,001 | $6.13 |
| Q1 2017 | +105,700 | New Buy | 105,700 | $7.34 |
| Q4 2016 | -85,100 | Sold Out | 0 | $0.00 |
| Q3 2016 | +44,000 | Add 107.06% | 85,100 | $3.01 |
| Q2 2016 | +10,700 | Add 35.20% | 41,100 | $2.77 |
| Q1 2016 | -6,800 | Reduce 18.28% | 30,400 | $2.89 |
| Q4 2015 | +37,200 | New Buy | 37,200 | $2.47 |
Renaissance Technologies (RenTech)'s Aurinia Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Aurinia Pharmaceuticals Inc. (AUPH) in Q4 2015, acquiring 37,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Aurinia Pharmaceuticals Inc. (AUPH) for 35 quarters since Q4 2015.
Renaissance Technologies (RenTech)'s largest addition to Aurinia Pharmaceuticals Inc. (AUPH) was in Q1 2022, adding 1,694,200 shares worth $20.97 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 1,590,135 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $25.36 M.
As of the Q4 2025 filing, Aurinia Pharmaceuticals Inc. (AUPH) represents approximately 0.04% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Aurinia Pharmaceuticals Inc. (AUPH) was 1,694,200 shares, as reported at the end of Q1 2022.